ASTRA was among the hosts and co-sponsors of a Congressional Briefing event titled, Ending Opioid Use; A New Hope, on October 11, 2018.
James Carroll (CEO, THOR Photomedicine), Prof. Praveen Arany (University at Buffalo, NY), Annette Quinn RN (Program Manager, Radiation Oncology, University of Pittsburgh (UPMC) Cancer Center) introduced Photobiomodulation (PBM) to a large gathering of senior policy officials at the Rayburn House Office Building.
One thing people not familiar with the heroin scene (which is a good thing) tend to find most surprising is heroin is not regarded by addicts, dealers, or professionals addressing the crises as even remotely an upgrade on prescription pain pills. Next to nobody starts out on heroin, which is cheaper to an extreme compared to prescription pill’s street prices...
“Overdoses on opioids -- such as prescription pain pills or heroin -- are killing 116 Americans every single day, more than 40,000 lives a year,” Health and Human Services Secretary Alex M. Azar II said during the ceremony. “Think about this: Almost 1-in-100 American babies are born dependent on drugs.”
August 27,2018 - Today, the U.S. Department of Energy (DOE) announced $8 million in funding for 12 research awards on a range of topics in both basic and use-inspired research in particle accelerator science and technology. Projects include work to develop faster methods of applying ion beams to help cure cancer, increase the power of ultrafast lasers, improve technology for industrial-scale accelerators, and research new methods of acceleration.
The first drug that takes advantage of this natural biological process, called RNA interference, was approved August 10 by the U.S. Food and Drug Administration. It targets a rare hereditary disease that causes misshapen proteins to build up in patients’ nerves, tissues and organs, causing loss of sensation, organ failure and even death.
Ryan Murphy, an economist at Southern Methodist University, recently published a working paper in which he ranked each of the states by the predominance of--there’s no nice way to put it--psychopaths. The winner? Washington in a walk. In fact, the capital scored higher on Murphy’s scale than the next two runners-up combined.
In April, the Congressional Budget Office reported the U.S. annual budget deficit will reach $1 trillion by 2020. That’s a troubling trajectory, but no one in Washington seems to care enough to stop spending money. I only see one answer. Washington needs to spend more money. Spending in one area now might actually help avert a fiscal apocalypse later.
According to research from the Society for Human Resource Management, citing Bureau of Labor Statistics (BLS) data, the percentage of boomers retiring has doubled over the past eight years and will continue to increase until the last of the boomers reach 65 around 2030. This is particularly challenging for manufacturers. Not only are more than a quarter of manufacturing workers over the age of 55, but the BLS also notes that manufacturers have the highest tenure compared to other sectors.
Coffee sellers are mulling how to fight a California judge’s ruling that would require the beverage to be branded with cancer warning labels. The National Coffee Association, whose members include Starbucks and Dunkin’ Donuts, said in a statement on Thursday that it was “currently considering all of its options, including potential appeals and further legal actions.”
Anyone without 20/20 vision can tell you about the struggles of wearing corrective lenses: Contacts often leave eyes tired and dry at the end of the day, and finding the perfect frames for your glasses can be a headache. But now nanotechnology could make it possible to correct vision using eye drops, which would eliminate the need for expensive and annoying eyewear.